Affiliate Disclosure: This article contains affiliate links. If you make a purchase through these links, I may earn a commission at no extra cost to you. My reviews are based on independent research and are intended for informational purposes only.
MEDVi Review : Fast, Affordable GLP-1 Weight Loss — Is It Worth It?
Quick Verdict
Our Rating: 8.7/10 — Excellent
Best For: Individuals seeking fast, affordable, and medically supervised access to compounded Semaglutide or Tirzepatide — with both injectable and oral tablet options, 24/7 provider support, unlimited telehealth visits, and free shipping across 49 states — all without insurance requirements or long-term contracts.
MEDVi has quietly become one of the most recognized names in the US GLP-1 telehealth market — and the numbers back it up. With over 10,000 verified patient reviews and a 4.5/5 Trustpilot rating, MEDVi has built a reputation for doing something the telehealth industry rarely delivers: fast approvals, transparent pricing, and genuine medical oversight — all in one streamlined platform.
Based in Newark, Delaware, MEDVi operates as a dedicated GLP-1 telehealth clinic that focuses exclusively on making prescription weight loss medications accessible and affordable. Unlike broader telehealth platforms that offer GLP-1s as one service among dozens, MEDVi has built its entire model around doing one thing exceptionally well — getting qualified patients started on clinically proven GLP-1 therapy as quickly and affordably as possible.
How It Works
MEDVi’s process is designed for speed and simplicity without compromising medical oversight. Most patients go from intake to prescription within 24-48 hours:
- Online Health Evaluation: Complete a comprehensive online questionnaire covering your medical history, weight loss goals, current medications, and basic health metrics. The intake is fully online and takes approximately five minutes. No in-person visit required.
- Licensed Provider Review: An independent, licensed US healthcare provider reviews your submission and determines your eligibility for GLP-1 therapy. In most states, a live telehealth appointment is not required — though patients in certain states may need to complete a live provider consultation before receiving a prescription, depending on local telehealth regulations.
- Medication Selection: Choose your preferred medication and format — injectable Semaglutide, oral Semaglutide tablets, injectable Tirzepatide, or oral Tirzepatide tablets. MEDVi offers one of the broadest medication menus in the GLP-1 telehealth category. Brand-name Ozempic and Wegovy are also available for patients who require FDA-approved options.
- Home Delivery & Ongoing Support: Your prescription is sent to one of MEDVi’s licensed US compounding pharmacy partners — including Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding — and shipped directly to your door at no additional cost. Unlimited 24/7 messaging and telehealth consultations with licensed providers are included in your monthly membership.
The Pros & Cons
What We Like (Pros):
- 10,000+ Verified Patient Reviews with 4.5/5 Rating: MEDVi has one of the largest verified patient review bases of any GLP-1 telehealth platform — a significant indicator of genuine patient satisfaction and clinical credibility.
- LegitScript Certified: MEDVi holds LegitScript certification — the telehealth industry’s most recognized independent compliance standard — confirming it meets transparency requirements and complies with all applicable state and federal laws.
- Broadest Medication Menu in the Category: Injectable Semaglutide, oral Semaglutide tablets, injectable Tirzepatide, oral Tirzepatide tablets, brand-name Ozempic, and brand-name Wegovy — all available through a single platform. Very few telehealth competitors offer this range.
- Fast Approvals — Medication Within 24 Hours: Most patients receive their prescription within 24-48 hours of completing their intake, with medication typically arriving within one week of approval.
- Unlimited 24/7 Provider Support: Unlimited messaging and telehealth consultations with licensed clinicians are included in the monthly membership — no per-visit fees.
- No Long-Term Contracts: MEDVi operates month-to-month with no minimum commitment required.
- Money-Back Guarantee: MEDVi stands behind its program with a satisfaction guarantee.
- Oral Tablet Options Available: MEDVi is one of the few telehealth platforms offering both injectable and oral tablet formulations of compounded Semaglutide and Tirzepatide — a meaningful option for needle-averse patients.
- Licensed Pharmacy Partners: All compounded medications are sourced from established, licensed US compounding pharmacies (including Triad Rx, RedRock, and Beaker Pharmacy) operating under USP standards.
What to Consider (Cons):
- Price Increases After First Month: MEDVi offers an introductory first-month rate, with ongoing refill pricing significantly higher. Always verify your full ongoing monthly cost before committing.
- Cash-Pay Only: MEDVi does not accept insurance. HSA/FSA reimbursement may be available depending on your plan.
- State-Specific Requirements May Apply: Depending on your state’s telehealth regulations, you may be required to complete a live provider consultation before receiving a prescription. Verify availability and requirements for your state during intake.
- Mixed Reviews on Billing and Cancellation: While the majority of patient reviews are positive, a notable portion flag billing issues and cancellation complications. MEDVi recommends contacting support proactively for any account management needs.
Pricing Breakdown
MEDVi offers competitive, transparent all-inclusive pricing with no separate membership fee:
- Compounded Semaglutide Injectable: $179 for the first month → $299/month ongoing (month-to-month), or $179/month on a 12-month prepaid plan.
- Compounded Semaglutide Oral Tablets: $249 for the first month → $369/month ongoing.
- Compounded Tirzepatide Injectable and Oral Tablets: $279 for the first month → $399/month ongoing, or $299/month on a 12-month prepaid plan.
- Brand-Name Ozempic: $750 first month → $950/month ongoing.
- Brand-Name Wegovy: $950 first month → $1,150/month ongoing.
- Shipping: Free on all orders.
- No Membership Fee: Monthly costs cover clinician consultation, medication, and free shipping — nothing more.
Who Is MEDVi Best For?
MEDVi is an excellent choice if you:
- Want fast, affordable access to compounded GLP-1 medications — Semaglutide or Tirzepatide — with approvals typically within 24-48 hours
- Value a broad medication menu including both injectable and oral tablet formats
- Want 24/7 unlimited provider support included in your monthly cost
- Prefer a no-contract, month-to-month model with no long-term commitment
- Are needle-averse and want an oral tablet alternative to injections
- Live in one of the 49 states where MEDVi operates
It may not be the right fit if your state requires in-person care, if you require insurance coverage for branded GLP-1 medications, or if mandatory lab testing before treatment is important to you.
Final Thoughts
MEDVi has earned its position as one of the most trusted names in the GLP-1 telehealth market through a straightforward but powerful formula: fast approvals, transparent pricing, a broad medication menu, and genuine 24/7 medical oversight — all without long-term contracts or hidden fees. With over 10,000 verified patient reviews, LegitScript certification, and one of the most accessible price points in the market, MEDVi is a compelling first choice for eligible Americans ready to start their GLP-1 weight loss journey in 2026.
Compare Similar GLP-1 Programs
If MEDVi doesn’t feel like the right fit, here are some similar programs worth considering:
Want the most affordable compounded GLP-1? Read our bmiMD Review — starting at $99/month with 80,000+ members served.
Looking for needle-free GLP-1 options? See our Embody GLP-1 Review — the only platform with oral Tirzepatide gum.
Need holistic coaching alongside medication? Check out our Fridays Health Review — unlimited dietitian coaching and insurance navigation included.
🩺 Medically Reviewed by Larysa Grevtsova, MD
Dermatologist & Aesthetic Medicine Specialist with 20 years of clinical experience, including injectable weight loss therapies and GLP-1 pharmacology.
